Advertisement
Advertisement

COLL

COLL logo

Collegium Pharmaceutical, Inc. Common Stock

37.80
USD
Sponsored
-1.53
-3.89%
May 08, 16:00 UTC -4
Closed
exchange

Pre-Market

37.83

+0.03
+0.08%

Collegium Pharmaceutical, Inc. Common Stock Profile

About

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are in different clinical trial. It developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, United States.

Info & Links

CEO

Vikram Karnani

Headquarters

100 Technology Center Drive
Stoughton, MA 02072, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

www.collegiumpharma.com

Auditor

Deloitte & Touche LLP

Share holders

11

Employees

423

Collegium Pharmaceutical, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

1.23B

Enterprise Value

1.74B

Enterprise Value/EBITDA(ttm)

4.21

Price to Earnings Ratio(ttm)

5.33

Price to Sales(ttm)

1.46

Price to Book(mrq)

3.69

Price to Cash(ytd)

2.32

Profitability

Gross Margin(ttm)

59.15%

Operating Margin(ttm)

32.96%

Profit Margin(ttm)

7.76%

Return on Equity(ttm)

98.65%

Return on Invested Capital(ttm)

6.11%

Return on Assets(ttm)

15.86%

Income Statement

Revenue(ttm)

796.33M

Revenue Per Share(ttm)

24.55

Gross Profit(ttm)

483.18M

EBITDA(ttm)3

413.37M

Net Income Available to Common(ttm)

74.95M

Diluted EPS(ttm)

1.71

Share Statistics

Beta (5Y Monthly)

0.77

52-Week Change

30.84%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

32.43M

Dividend Yield

0.00%

Float4

31.59M

% Held by Insiders

2.51%

% Held by Institutions

--

Balance Sheet

Total Cash(mrq)

441.60M

Total Cash Per Share(mrq)

13.62

Total Debt(mrq)

802.82M

Total Debt/Equity(mrq)

268.28%

Current Ratio(mrq)

1.57%

Quick Ratio(mrq)

1.48%

Book Value Per Share(mrq)

9.51

Cash Flow

Operating Cash Flow Per Share(ytd)

8.29

Free Cash Flow(ytd)

327.58M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement